BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 34276672)

  • 21. Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology.
    Kumar A; Kumar S; Narayan RK; Kumari C; Pareek V; Prasoon P
    Viral Immunol; 2021 Jun; 34(5):352-357. PubMed ID: 33481684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA Sequencing in COVID-19 patients identifies neutrophil activation biomarkers as a promising diagnostic platform for infections.
    Wargodsky R; Dela Cruz P; LaFleur J; Yamane D; Kim JS; Benjenk I; Heinz E; Irondi OO; Farrar K; Toma I; Jordan T; Goldman J; McCaffrey TA
    PLoS One; 2022; 17(1):e0261679. PubMed ID: 35081105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.
    Yan Q; Li P; Ye X; Huang X; Feng B; Ji T; Chen Z; Li F; Zhang Y; Luo K; Chen F; Mo X; Wang J; Feng L; Hu F; Lei C; Qu L; Chen L
    J Immunol; 2021 May; 206(9):2146-2159. PubMed ID: 33846224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic reprograming shapes neutrophil functions in severe COVID-19.
    Borella R; De Biasi S; Paolini A; Boraldi F; Lo Tartaro D; Mattioli M; Fidanza L; Neroni A; Caro-Maldonado A; Meschiari M; Franceschini E; Quaglino D; Guaraldi G; Bertoldi C; Sita M; Busani S; Girardis M; Mussini C; Cossarizza A; Gibellini L
    Eur J Immunol; 2022 Mar; 52(3):484-502. PubMed ID: 34870329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19.
    Shi J; Zhou J; Zhang X; Hu W; Zhao JF; Wang S; Wang FS; Zhang JY
    Front Immunol; 2021; 12():700152. PubMed ID: 34394094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies.
    Panda R; Castanheira FV; Schlechte JM; Surewaard BG; Shim HB; Zucoloto AZ; Slavikova Z; Yipp BG; Kubes P; McDonald B
    JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34908534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-Cell Landscape of Lungs Reveals Key Role of Neutrophil-Mediated Immunopathology during Lethal SARS-CoV-2 Infection.
    Zheng XS; Wang Q; Min J; Shen XR; Li Q; Zhao QC; Wang X; Jiang RD; Geng R; Chen Y; Zhu Y; Li B; Zhang W; Li A; Xie TT; Liu MQ; Cheng L; Shi ZL; Zhou P
    J Virol; 2022 May; 96(9):e0003822. PubMed ID: 35420442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic and features of SARS-CoV-2 infection in Gabon.
    Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
    Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
    Glans H; Gredmark-Russ S; Olausson M; Falck-Jones S; Varnaite R; Christ W; Maleki KT; Karlberg ML; Broddesson S; Falck-Jones R; Bell M; Johansson N; Färnert A; Smed-Sörensen A; Klingström J; Bråve A
    BMC Infect Dis; 2021 May; 21(1):494. PubMed ID: 34044758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19.
    Wang JY; Zhang W; Roehrl VB; Roehrl MW; Roehrl MH
    Front Immunol; 2022; 13():831849. PubMed ID: 35401574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue-Specific Immunopathology in Fatal COVID-19.
    Dorward DA; Russell CD; Um IH; Elshani M; Armstrong SD; Penrice-Randal R; Millar T; Lerpiniere CEB; Tagliavini G; Hartley CS; Randle NP; Gachanja NN; Potey PMD; Dong X; Anderson AM; Campbell VL; Duguid AJ; Al Qsous W; BouHaidar R; Baillie JK; Dhaliwal K; Wallace WA; Bellamy COC; Prost S; Smith C; Hiscox JA; Harrison DJ; Lucas CD
    Am J Respir Crit Care Med; 2021 Jan; 203(2):192-201. PubMed ID: 33217246
    [No Abstract]   [Full Text] [Related]  

  • 32. Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.
    Lichtensteiger C; Koblischke M; Berner F; Jochum AK; Sinnberg T; Balciunaite B; Purde MT; Walter V; Abdou MT; Hofmeister K; Kohler P; Vernazza P; Albrich WC; Kahlert CR; Zoufaly A; Traugott MT; Kern L; Pietsch U; Kleger GR; Filipovic M; Kneilling M; Cozzio A; Pop O; Bomze D; Bergthaler A; Hasan Ali O; Aberle J; Flatz L
    J Autoimmun; 2023 Nov; 140():103118. PubMed ID: 37826919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
    Wang B; Wang L; Kong X; Geng J; Xiao D; Ma C; Jiang XM; Wang PH
    J Med Virol; 2020 Sep; 92(9):1684-1689. PubMed ID: 32343415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung Neutrophilic Recruitment and IL-8/IL-17A Tissue Expression in COVID-19.
    Azevedo MLV; Zanchettin AC; Vaz de Paula CB; Motta Júnior JDS; Malaquias MAS; Raboni SM; Neto PC; Zeni RC; Prokopenko A; Borges NH; Godoy TM; Benevides APK; de Souza DG; Baena CP; Machado-Souza C; de Noronha L
    Front Immunol; 2021; 12():656350. PubMed ID: 33868301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia.
    Nicolai L; Leunig A; Brambs S; Kaiser R; Joppich M; Hoffknecht ML; Gold C; Engel A; Polewka V; Muenchhoff M; Hellmuth JC; Ruhle A; Ledderose S; Weinberger T; Schulz H; Scherer C; Rudelius M; Zoller M; Keppler OT; Zwißler B; von Bergwelt-Baildon M; Kääb S; Zimmer R; Bülow RD; von Stillfried S; Boor P; Massberg S; Pekayvaz K; Stark K
    J Thromb Haemost; 2021 Feb; 19(2):574-581. PubMed ID: 33217134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2.
    Chan YH; Fong SW; Poh CM; Carissimo G; Yeo NK; Amrun SN; Goh YS; Lim J; Xu W; Chee RS; Torres-Ruesta A; Lee CY; Tay MZ; Chang ZW; Lee WH; Wang B; Tan SY; Kalimuddin S; Young BE; Leo YS; Wang CI; Lee B; Rötzschke O; Lye DC; Renia L; Ng LFP
    EMBO Mol Med; 2021 Jun; 13(6):e14045. PubMed ID: 33961735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.
    Vojdani A; Vojdani E; Kharrazian D
    Front Immunol; 2020; 11():617089. PubMed ID: 33584709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2-infected patients by sex and age.
    Freire PP; Marques AH; Baiocchi GC; Schimke LF; Fonseca DL; Salgado RC; Filgueiras IS; Napoleao SM; Plaça DR; Akashi KT; Hirata TDC; El Khawanky N; Giil LM; Cabral-Miranda G; Carvalho RF; Ferreira LCS; Condino-Neto A; Nakaya HI; Jurisica I; Ochs HD; Camara NOS; Calich VLG; Cabral-Marques O
    JCI Insight; 2021 May; 6(10):. PubMed ID: 34027897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection.
    Saheb Sharif-Askari N; Saheb Sharif-Askari F; Mdkhana B; Al Heialy S; Alsafar HS; Hamoudi R; Hamid Q; Halwani R
    Mol Ther Methods Clin Dev; 2021 Mar; 20():109-121. PubMed ID: 33200082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.